CHRISTYL CHAMPION: Open Payments
NPI 1396413092 · TEGA CAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 25 payments from 12 companies in 2025. Trend: 2023 $172 · 2024 $17 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Supernus Pharmaceuticals, Inc. | 2 | $58 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Tris Pharma Inc | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Neos Therapeutics, LP | 1 | $20 |
Products named: VRAYLAR, REXULTI, TRINTELLIX, Qelbree, Auvelity, CAPLYTA, Onyda XR, SPRAVATO.
Industry payments across SC — which companies pay providers there.
